Cargando…

The Essential Role of Body Weight in Adjusting Gn Dosage to Prevent High Ovarian Response for Women With PCOS During IVF: A Retrospective Study

Polycystic ovarian syndrome (PCOS) is the major cause of anovulatory infertility. Since women with PCOS are often accompanied by increased body weight and hyper response to controlled ovarian stimulation, individualized gonadotropin (Gn) dose is required to achieve a therapeutic effect while minimiz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Rujun, Chen, Hanxiao, Zeng, Xun, Qin, Lang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283682/ https://www.ncbi.nlm.nih.gov/pubmed/35846308 http://dx.doi.org/10.3389/fendo.2022.922044

Ejemplares similares

GnRH Antagonist IVF Protocol in PCOS
por: Onofriescu, Alina, et al.
Publicado: (2013)

Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist
por: Lv, Mu, et al.
Publicado: (2022)

Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF
por: Zhang, Dan, et al.
Publicado: (2018)

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
por: Orvieto, Raoul, et al.
Publicado: (2020)

Follicular-Phase GnRH Agonist Protocol Is Another Choice for Polycystic Ovary Syndrome Patients With Lower LH/FSH and Lower AMH Levels Without Increasing Severe OHSS Risk
por: Gao, Rui, et al.
Publicado: (2022)

Insulin Resistance Adversely Affect IVF Outcomes in Lean Women Without PCOS
por: Wang, Haoyu, et al.
Publicado: (2021)

Potential biomarkers for clinical outcomes of IVF cycles in women with/without PCOS: Searching with metabolomics
por: Guan, Shang-yue, et al.
Publicado: (2022)

Influencing of serum inflammatory factors on IVF/ICSI outcomes among PCOS patients with different BMI
por: He, Yilei, et al.
Publicado: (2023)

High initial FSH dosage reduces the number of available cleavage-stage embryos in a GnRH-antagonist protocol: Real-world data of 8,772 IVF cycles from China
por: Luo, Xiu, et al.
Publicado: (2022)

Empty Follicle Syndrome Following GnRHa Trigger in PCOS Patients Undergoing IVF Cycles
por: Deepika, Krishna, et al.
Publicado: (2018)

Comparison of Cumulative Live Birth Rate Between Aged PCOS Women and Controls in IVF/ICSI Cycles
por: Mai, Zhuoyao, et al.
Publicado: (2021)

Endocrine Requirements for Oocyte Maturation Following hCG, GnRH Agonist, and Kisspeptin During IVF Treatment
por: Abbara, Ali, et al.
Publicado: (2020)

Effect of weight loss on pregnancy outcomes, neuronal-reproductive-metabolic hormones and gene expression profiles in granulosa cells in obese infertile PCOS patients undergoing IVF-ET
por: Wu, Limin, et al.
Publicado: (2022)

HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study
por: Zeng, Hong, et al.
Publicado: (2022)

Self-Detection of the LH Surge in Urine After GnRH Agonist Trigger in IVF—How to Minimize Failure to Retrieve Oocytes
por: Cozzolino, Mauro, et al.
Publicado: (2020)

Development and Validation of a Clinical Pregnancy Failure Prediction Model for Poor Ovarian Responders During IVF/ICSI
por: Li, Fangyuan, et al.
Publicado: (2021)

Mild starting dosage ovarian stimulation combined with a modified prolonged GnRH-a protocol improved IVF/ICSI outcomes in normal ovarian responders
por: Tian, Li-Feng, et al.
Publicado: (2019)

Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Supposed Normal Ovarian Responders Undergoing IVF: A Systematic Review and Meta-Analysis
por: Xiao, Jin-song, et al.
Publicado: (2014)

Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study
por: Lan, Jie, et al.
Publicado: (2021)

Outcomes of a GnRH Agonist Trigger Following a GnRH Antagonist or Flexible Progestin-Primed Ovarian Stimulation Cycle
por: Kalafat, Erkan, et al.
Publicado: (2022)

Stop GnRH-agonist/GnRH-antagonist protocol: a different insight on ovarian stimulation for IVF
por: Orvieto, Raoul
Publicado: (2023)

A modified GnRH antagonist method in combination with letrozole, cabergoline, and GnRH antagonist for PCOS: Safe and effective ovarian stimulation to treat PCOS and prevent OHSS
por: Yanagihara, Yasuho, et al.
Publicado: (2021)

HCG trigger versus GnRH agonist trigger in PCOS patients undergoing IVF cycles: frozen embryo transfer outcomes
por: Deepika, Krishna, et al.
Publicado: (2021)

Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
por: Huang, Jialyu, et al.
Publicado: (2019)

Use of Growth Hormone in the IVF Treatment of Women With Poor Ovarian Reserve
por: Hart, Roger J.
Publicado: (2019)

What Is the Best Regimen for Ovarian Stimulation of Poor Responders in ART/IVF?
por: Blumenfeld, Zeev
Publicado: (2020)

The homeostasis model assessment of insulin resistance is a judgment criterion for metformin pre-treatment before IVF/ICSI and embryo transfer cycles in patients with polycystic ovarian syndrome
por: Gao, Rui, et al.
Publicado: (2023)

Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers
por: Garrido, Maritza P., et al.
Publicado: (2023)

A prediction model for high ovarian response in the GnRH antagonist protocol
por: Jiang, Yilin, et al.
Publicado: (2023)

High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients
por: Guo, Yaxin, et al.
Publicado: (2021)

Impact of growth hormone on IVF/ICSI outcomes and endometrial receptivity of patients undergoing GnRH antagonist protocol with fresh embryo transfer: a pilot study
por: Chu, Yifan, et al.
Publicado: (2023)

Does Serum LH Level Influence IVF Outcomes in Women with PCOS Undergoing GnRH-Antagonist Stimulation: A Novel Indicator
por: Wang, Jing, et al.
Publicado: (2022)

Central Regulation of PCOS: Abnormal Neuronal-Reproductive-Metabolic Circuits in PCOS Pathophysiology
por: Liao, Baoying, et al.
Publicado: (2021)

The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist
por: Seyhan, Ayse, et al.
Publicado: (2011)

The Optimal Number of Oocytes Retrieved From PCOS Patients Receiving IVF to Obtain Associated With Maximum Cumulative Live Birth Rate and Live Birth After Fresh Embryo Transfer
por: Jia, Rui, et al.
Publicado: (2022)

Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
por: Flanagan, Colleen A., et al.
Publicado: (2017)

The role of GnRH metabolite, GnRH-(1-5), in endometrial cancer
por: Cho-Clark, Madelaine J., et al.
Publicado: (2023)

The Relationship Between Serum Delta FSH Level and Ovarian Response in IVF/ICSI Cycles
por: Hu, Linli, et al.
Publicado: (2020)

Editorial: Ovarian Stimulation, Endocrine Responses and Impact Factors Affecting the Outcome of IVF Treatment
por: Lawrenz, Barbara, et al.
Publicado: (2022)

GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile
por: Chaudhari, Nirja, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u7fpjjtm28nbro1vvo69jk0vhl